NAGE
NASDAQ · Life Sciences Tools & Services
Niagen Bioscience Inc
$5.20
+0.07 (+1.36%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+232.1% upside
Low Target
$12.09
Average Target
$17.27
High Target
$22.08
Current Price
$5.20
Current
$5.20
$5.20
Target
$17.27
$17.27
$12.09
$17.27 avg
$22.08
Scenario Analysis
Bear Case
$12.09
132.5%
Low target
Base Case
$17.27
+232.1%
Avg target
Bull Case
$22.08
+324.6%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$14.69
-64.6% from high
52-Week Low
$5.05
+3.0% from low
Target vs 52W High
$17.27
+17.6% vs high
Next Earnings Report
Mar 4, 2026 · After Market Close
15d
until earnings
EPS Est: $0.02
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 82% | $369.21 | -32.0% |
| DHR | Strong Buy | 31 | 87% | $158.11 | -25.6% |
| A | Buy | 29 | 72% | $64.69 | -50.1% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -55.8% |
| MTD | Hold | 21 | 43% | $170.43 | -87.6% |
| WAT | Buy | 25 | 56% | $189.60 | -50.3% |
| ILMN | Hold | 26 | 50% | $169.36 | +41.5% |
| WST | Strong Buy | 23 | 78% | $136.24 | -45.3% |